Cibus, Inc. (NASDAQ:CBUS) Sees Large Increase in Short Interest

Cibus, Inc. (NASDAQ:CBUS - Get Free Report) saw a significant growth in short interest during the month of September. As of September 15th, there was short interest totalling 2,410,000 shares, a growth of 11.6% from the August 31st total of 2,160,000 shares. Approximately 13.7% of the shares of the company are short sold. Based on an average daily volume of 222,700 shares, the days-to-cover ratio is presently 10.8 days.

Cibus Price Performance

Shares of CBUS traded down $0.06 during trading hours on Friday, reaching $3.35. 222,442 shares of the company's stock traded hands, compared to its average volume of 130,409. Cibus has a twelve month low of $3.33 and a twelve month high of $23.18. The business's fifty day simple moving average is $6.78 and its two-hundred day simple moving average is $12.04. The firm has a market capitalization of $72.18 million, a price-to-earnings ratio of -0.18 and a beta of 1.84.

Cibus (NASDAQ:CBUS - Get Free Report) last released its quarterly earnings results on Thursday, August 8th. The company reported ($1.14) EPS for the quarter, missing analysts' consensus estimates of ($0.81) by ($0.33). The company had revenue of $0.84 million for the quarter, compared to the consensus estimate of $0.44 million. Cibus had a negative return on equity of 29.05% and a negative net margin of 9,856.84%. During the same quarter last year, the firm posted ($3.05) earnings per share. On average, equities research analysts expect that Cibus will post -3.84 EPS for the current year.

Analyst Ratings Changes

Several analysts recently issued reports on CBUS shares. Alliance Global Partners cut their price target on Cibus from $25.00 to $23.50 and set a "buy" rating on the stock in a report on Tuesday, September 24th. Canaccord Genuity Group dropped their price objective on shares of Cibus from $21.00 to $20.00 and set a "buy" rating on the stock in a report on Thursday, September 19th. Finally, Canaccord Genuity Group raised shares of Cibus to a "strong-buy" rating in a research note on Friday, July 19th.

Institutional Investors Weigh In On Cibus

A number of institutional investors have recently added to or reduced their stakes in the company. FineMark National Bank & Trust lifted its holdings in shares of Cibus by 24.3% in the second quarter. FineMark National Bank & Trust now owns 20,488 shares of the company's stock valued at $202,000 after buying an additional 4,000 shares during the period. Squarepoint Ops LLC bought a new position in shares of Cibus in the second quarter valued at $214,000. Rhumbline Advisers acquired a new stake in shares of Cibus during the second quarter worth $221,000. Old West Investment Management LLC boosted its position in shares of Cibus by 3.6% in the 2nd quarter. Old West Investment Management LLC now owns 53,247 shares of the company's stock valued at $524,000 after purchasing an additional 1,868 shares during the period. Finally, Bank of New York Mellon Corp acquired a new stake in Cibus during the 2nd quarter worth about $529,000. 33.81% of the stock is currently owned by institutional investors and hedge funds.

About Cibus

Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.